Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Appropriations Bill Moves To House Floor With $2.995 Billion For FDA

This article was originally published in The Tan Sheet

Executive Summary

The House Appropriations bill that passed out of committee June 18 would give FDA $2.995 billion, including user fees, which allows the agency to hire new staff to examine thousands more imported food and drug products

You may also be interested in...



FDA "Not Happy" Without NDI Guidance, Works To Improve Acceptance Rates

FDA is working to raise the acceptance rate for new dietary ingredient notifications from the current level of roughly 25 percent even as much-needed industry guidance is delayed, a Center for Food Safety and Applied Nutrition executive says

FDA "Not Happy" Without NDI Guidance, Works To Improve Acceptance Rates

FDA is working to raise the acceptance rate for new dietary ingredient notifications from the current level of roughly 25 percent even as much-needed industry guidance is delayed, a Center for Food Safety and Applied Nutrition executive says

FDA "Not Happy" Without NDI Guidance, Works To Improve Acceptance Rates

FDA is working to raise the acceptance rate for new dietary ingredient notifications from the current level of roughly 25 percent even as much-needed industry guidance is delayed, a Center for Food Safety and Applied Nutrition executive says

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103029

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel